Atlas Trials

Squamous Cell Carcinoma, Head And Neck

9 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Squamous Cell Carcinoma, Head And Neck

RecordFirmDate
Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer (NCT06736379)VLP Therapeutics2025-05-13
Sitravatinib (MGCD516) and Nivolumab in Oral Cavity Cancer Window Opportunity Study (NCT03575598)University Health Network, Toronto2018-08-30
Pre-operative Mocetinostat (MGCD0103) and Durvalumab (MEDI4736) (PRIMED) for Squamous Cell Carcinoma of the Oral Cavity (NCT02993991)University Health Network, Toronto2017-10-10
Study Comparing AlloVax™ to Chemotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head & Neck (NCT02624999)Mirror Biologics, Inc.2016-12-01
Ficlatuzumab and Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) (NCT02277197)James J Lee2015-08-01
Mitomycin C in Patients With Incurable p16 Positive Oropharyngeal and p16 Negative Head and Neck Squamous Cell Carcinoma (HNSCC) Resistant to Standard Therapies (NCT02369458)Washington University School of Medicine2015-04-14
Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma (NCT02296684)Washington University School of Medicine2015-03-25
Safety and Efficacy of Radiation/Cetuximab Plus EGFR Antisense DNA for Head and Neck Squamous Cell Carcinoma (NCT00903461)University of Pittsburgh2012-04-01
A Phase II Trial Evaluating WNT974 in Patients With Metastatic Head and Neck Squamous Cell Carcinoma (NCT02649530)University of Michigan Rogel Cancer Center

Track Squamous Cell Carcinoma, Head And Neck automatically

Every clearance here is in the API, with alerts when new ones post.